|
|
|
Volumn 6, Issue 4, 1999, Pages 216-
|
|
L-Ornithine aspartate - A rationale for its use in combination with chemotherapy, radiation, and hyperthermia in oncology
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOTRANSFERASE;
AMMONIA;
ANTINEOPLASTIC AGENT;
ASPARTATE AMMONIA LIGASE;
CHOLINESTERASE;
MUSCLE PROTEIN;
ORNITHINE ASPARTATE;
UREA;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
HUMAN;
HYPERAMMONEMIA;
HYPERTHERMIC THERAPY;
LETTER;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN;
PROTEIN DEGRADATION;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
DIPEPTIDES;
HUMANS;
NEOPLASMS;
|
|
EID: 0032885699
PISSN: 10217096
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (2)
|
|
References (10)
|